Better Treatment Outcomes Start With the Right Tools.
PHD Laboratory supports behavioral health and SUD treatment programs with two critical diagnostic services: pharmacogenomic testing to optimize psychiatric medications, and toxicology testing to monitor patient compliance and safety.
Two Diagnostic Services Your Program Needs
Together, PGx and toxicology testing close the two biggest clinical gaps in behavioral health treatment.
Pharmacogenomics (PGx)
Know how your patient's DNA affects their response to psychiatric medications — before the first dose. Stop the trial-and-error cycle that drives dropout.
- SSRIs, SNRIs, TCAs, antipsychotics covered
- Addiction treatment meds (Suboxone, Naltrexone)
- One test — lifetime of clinical value
- 200+ medications across 20+ specialties
Clinical Toxicology
Accurate urine and oral fluid drug testing for SUD compliance monitoring, medication adherence verification, and patient safety protocols.
- Compliance monitoring for MAT patients
- Confirm prescribed medication adherence
- Detect illicit substance use
- Fast turnaround for clinical decision-making
The Medication Problem Driving Behavioral Health Dropout.
When patients cycle through antidepressants or mood stabilizers that don't work — or cause intolerable side effects — they disengage from treatment entirely. And without toxicology monitoring, compliance and safety drift undetected.
- 40–60% of patients with depression don't respond to the first antidepressant
- Side effects are the #1 reason patients stop psychiatric medication
- Genetic variants affect SSRIs, SNRIs, antipsychotics, and mood stabilizers
- SUD patients without tox monitoring have higher relapse rates
PHD Lab By the Numbers
Comprehensive Psychiatric & SUD Medication Coverage
Antidepressants
- SSRIs (Sertraline, Fluoxetine, Escitalopram)
- SNRIs (Venlafaxine, Duloxetine)
- TCAs (Amitriptyline)
- MAOIs
Antipsychotics & Mood Stabilizers
- Risperidone
- Aripiprazole
- Quetiapine
- Lithium monitoring support
Addiction Treatment
- Buprenorphine / Suboxone
- Naltrexone
- Methadone
- Opioid metabolism profiling
Why Behavioral Health Organizations Partner With PHD Lab
Built for Psychiatric Complexity
Our panel maps both pharmacokinetics and pharmacodynamics — critical nuances often missed by screening labs.
Reduces Patient Dropout
When medications work faster with fewer side effects, patient engagement and adherence improve dramatically.
CLIA/COLA Certified
High-complexity accreditation means your clinical and compliance teams can trust and cite our results.
Staff Education & Support
We provide training resources and genetic counselor support so your team can confidently apply results.
"We saw a measurable improvement in patient retention after implementing PGx testing in our intake process. Patients who previously cycled through 3–4 medications were stabilized much faster."
— Behavioral Health Program Director
Bring Precision Diagnostics to Your Program
Let's discuss how PGx and toxicology testing can integrate into your intake and treatment planning process.
Talk to Our Team